Jakob Lind - Qlife Holding Global Clinical

All Insiders Sweden . 
Stock . Qlife Holding AB . Stakeholders . Insider . Jakob Lind
QLIFE Stock  SEK 2.24  0.04  1.82%   

Insider

Jakob Lind is Global Clinical of Qlife Holding AB
Phone45 21 63 35 34
Webhttps://www.qlifeholding.com

Qlife Holding Management Efficiency

The company has return on total asset (ROA) of (0.2688) % which means that it has lost $0.2688 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6144) %, meaning that it generated substantial loss on money invested by shareholders. Qlife Holding's management efficiency ratios could be used to measure how well Qlife Holding manages its routine affairs as well as how well it operates its assets and liabilities.
Qlife Holding AB has accumulated 2.76 M in total debt with debt to equity ratio (D/E) of 0.02, which may suggest the company is not taking enough advantage from borrowing. Qlife Holding AB has a current ratio of 6.32, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Qlife Holding until it has trouble settling it off, either with new capital or with free cash flow. So, Qlife Holding's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Qlife Holding AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Qlife to invest in growth at high rates of return. When we think about Qlife Holding's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Robert HrdMekonomen AB
57
Jonas TidqvistKABE Group AB
54
Johan SkogerydKABE Group AB
N/A
Haydn PoveyIAR Systems Group
53
Mats EkelundClinical Laserthermia Systems
N/A
Viktor TrojeforsKABE Group AB
32
Marie KarlssonEmbellence Group AB
N/A
LarsErik ErikssonClinical Laserthermia Systems
74
Kent SanderTriboron International AB
70
Par IhrskogEmbellence Group AB
N/A
Christian TomadiniEmbellence Group AB
N/A
Jan NormanTriboron International AB
66
Ian FieldTriboron International AB
69
Jesper RydakerIAR Systems Group
53
Henrik DamgaardNorva24 Group AB
46
Lotta SamuelsonEmbellence Group AB
N/A
LarsErik HenrikssonEmbellence Group AB
N/A
Marie MScClinical Laserthermia Systems
44
Dan MogrenClinical Laserthermia Systems
N/A
Bertolt GartnerNorva24 Group AB
56
Piotr ZyskMekonomen AB
N/A
Qlife Holding AB , a high-tech medical device company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company was incorporated in 2019 and is based in Helsingborg, Sweden. QLife Holding is traded on Stockholm Stock Exchange in Sweden. Qlife Holding AB (QLIFE) is traded on Stockholm Exchange in Sweden and employs 61 people.

Management Performance

Return On Equity-0.61
Return On Asset-0.27

Qlife Holding AB Leadership Team

Elected by the shareholders, the Qlife Holding's board of directors comprises two types of representatives: Qlife Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Qlife. The board's role is to monitor Qlife Holding's management team and ensure that shareholders' interests are well served. Qlife Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Qlife Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jakob Lind, Global Clinical
Thomas Warthoe, CEO CoFounder
Peter Warthoe, CoFounder Officer
Kasper Rousoe, Chief Officer

Qlife Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Qlife Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.61
Return On Asset-0.27
Profit Margin(1.45) %
Operating Margin(1.58) %
Current Valuation55.76 M
Shares Outstanding23.07 M
Shares Owned By Insiders10.99 %
Shares Owned By Institutions9.73 %
Price To Book0.32 X
Price To Sales0.54 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Qlife Stock Analysis

When running Qlife Holding's price analysis, check to measure Qlife Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Qlife Holding is operating at the current time. Most of Qlife Holding's value examination focuses on studying past and present price action to predict the probability of Qlife Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Qlife Holding's price. Additionally, you may evaluate how the addition of Qlife Holding to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY